MLchartDataset catalogue

temanogrel hydrochloride

Term · Oncology and biomedicine · MLC-T-ONC-017059

The hydrochloride salt form of temanogrel, an orally bioavailable, selective inverse agonist of 5-hydroxytryptamine receptor 2A (5-HT2A), with potential anti-thrombotic and vasodilating activities. Upon oral administration, temanogrel targets, binds to and inhibits 5-HT2A expressed on platelet surfaces and in smooth muscle cells, thereby inhibiting 5-HT-mediated platelet aggregation and vasoconstriction. This may attenuate platelet aggregation and vasoconstriction, and improve blood flow.

Table 1. Record
IdentifierMLC-T-ONC-017059
FieldOncology and biomedicine
SynonymsTemanogrel
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017059",
  "term": "temanogrel hydrochloride",
  "field": "Oncology and biomedicine",
  "definition": "The hydrochloride salt form of temanogrel, an orally bioavailable, selective inverse agonist of 5-hydroxytryptamine receptor 2A (5-HT2A), with potential anti-thrombotic and vasodilating activities. Upon oral administration, temanogrel targets, binds to and inhibits 5-HT2A expressed on platelet surfaces and in smooth muscle cells, thereby inhibiting 5-HT-mediated platelet aggregation and vasoconstriction. This may attenuate platelet aggregation and vasoconstriction, and improve blood flow.",
  "synonyms": [
    "Temanogrel"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/temanogrel-hydrochloride/"
}

Record 16,131 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.